Search - tctmd.com

Displaying 421 - 440 of 540

Sort: Relevancy | Date

News Conference News AHA 2015

SPRINT Makes Case for Even Lower BP Target in Many Hypertensive Patients

Todd Neale

November 08, 2015

News Conference News AHA 2015

AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More

Shelley Wood

November 05, 2015

News Daily News

Battle Scars: Combat Injury Linked With Cardiovascular Risk

Caitlin E. Cox

November 04, 2015

News Daily News

ADAPT-DES Analysis Reopens Debate Over Possible PPI, Clopidogrel Interaction

Caitlin E. Cox

October 28, 2015

News Conference News TCT 2015

DISCOVER Registry: Positive Results Seen for Next-Generation TAVR Device at 1 Year

October 12, 2015

News Conference News TCT 2015

Asian TAVR Registry Shows Good Procedural and Clinical Results

October 11, 2015

News Daily News

In the Early Days of TAVR, No Mortality Penalty for Patients Treated Outside of Trial Centers

October 01, 2015

News Daily News

血流动力学抑制与肾脏疾病患者行 CAS 后的肾损伤相关

L.A. McKeown

September 28, 2015

News Daily News

La Depresión Hemodinámica se asoció a la Lesión Renal Post-CAS en Pacientes con Enfermedad Renal

L.A. McKeown

September 28, 2015

News Daily News

Hemodynamic Depression Tied to Kidney Injury After CAS in Patients With Renal Disease

L.A. McKeown

September 28, 2015

News Industry News

Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor

August 31, 2015

News Industry News

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

August 31, 2015

News Daily News

A-fib, Whether Preexisting or New-Onset, Tied to Poor Outcomes in TAVR

Yael L. Maxwell

August 30, 2015

News Daily News

Real-World LVAD Use Promising in Patients Otherwise Considered Too Sick for PCI

L.A. McKeown

August 24, 2015

News Industry News

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

August 14, 2015

News Daily News

PCI前肾功能评估的方法选择很重要

L.A. McKeown

June 29, 2015

News Daily News

Method Chosen to Estimate Pre-PCI Kidney Function Matters

L.A. McKeown

June 29, 2015

News Daily News

El Método Elegido para Calcular la Función Renal Pre-PCI es Relevante

L.A. McKeown

June 29, 2015

News Industry News

Resverlogix Officially Attains Phase 3 Status with a European Regulatory Authority

June 22, 2015

Advertisement

SPRINT Makes Case for Even Lower BP Target in Many Hypertensive Patients

AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More

Battle Scars: Combat Injury Linked With Cardiovascular Risk

ADAPT-DES Analysis Reopens Debate Over Possible PPI, Clopidogrel Interaction

DISCOVER Registry: Positive Results Seen for Next-Generation TAVR Device at 1 Year

Asian TAVR Registry Shows Good Procedural and Clinical Results

In the Early Days of TAVR, No Mortality Penalty for Patients Treated Outside of Trial Centers

血流动力学抑制与肾脏疾病患者行 CAS 后的肾损伤相关

La Depresión Hemodinámica se asoció a la Lesión Renal Post-CAS en Pacientes con Enfermedad Renal

Hemodynamic Depression Tied to Kidney Injury After CAS in Patients With Renal Disease

Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

A-fib, Whether Preexisting or New-Onset, Tied to Poor Outcomes in TAVR

Real-World LVAD Use Promising in Patients Otherwise Considered Too Sick for PCI

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

PCI前肾功能评估的方法选择很重要

Method Chosen to Estimate Pre-PCI Kidney Function Matters

El Método Elegido para Calcular la Función Renal Pre-PCI es Relevante

Resverlogix Officially Attains Phase 3 Status with a European Regulatory Authority

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content